Interactions between helminths and tuberculosis infections: Implications for tuberculosis diagnosis and vaccination

Simeon I Cadmus1,2, Victor O Akinseye1, Babafemi O Taiwo3

  • 1Depeartment of Veterinary Public Health & Preventive Medicine, University of Ibadan, Ibadan, Nigeria.

Insights

In Africa, nearly half of school children have parasitic worm infections, increasing tuberculosis (TB) risk. Research is needed on helminth-TB co-infections and their impact on immunity and TB control.

Area of Science:

  • Tropical Medicine
  • Immunology
  • Infectious Diseases

Background:

  • Sub-Saharan Africa faces significant health challenges, with high rates of parasitic helminth infections among school-aged children.
  • Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a leading cause of death in the region.
  • The interplay between helminth infections and TB pathogenesis is under-researched, despite helminths' potential to modulate host immunity.

Purpose of the Study:

  • To review the challenges posed by helminth-TB co-infections in the African context.
  • To highlight the impact of helminth infections on host immune responses relevant to TB.
  • To emphasize the need for further research into helminth-TB interactions for improved TB control and vaccination strategies.

Main Methods:

  • This is a review article, synthesizing existing research on helminth infections and tuberculosis in Africa.
  • Analysis of immune responses, specifically T-helper type 1 (Th1) and T-helper type 2 (Th2) pathways.
  • Examination of the epidemiological and immunological implications of co-infections.

Main Results:

  • Helminth infections are highly prevalent in African school-aged children, affecting nearly half of the population.
  • Helminths induce Th2 and immune-regulatory responses, which contrast with the Th1 response required for protection against active TB.
  • Chronic helminth infections may significantly impact TB susceptibility, diagnosis, and vaccine efficacy.

Conclusions:

  • Helminth-TB co-infections present a complex challenge to public health in Africa.
  • Understanding the immunological consequences of co-infections is crucial for developing effective TB prevention and treatment strategies.
  • Further research is urgently needed to address the neglected area of helminth-TB interactions in Africa.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
422
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
736
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
465
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
792
Vaccinations01:51

Vaccinations

Overview
50.8K